Plaintiffs: Allergan Promoted Off-Label Use of Botox
In Orange County, California, opening statements began yesterday in a multi-plaintiff civil case against Allergan, maker of Botox. The plaintiffs, including the mother...
Read More
-
About Pathophilia
Top 10 for ’09: No. 3
No. 3: The Transparency Movement Takes a Vice-Like Hold The push to uncover every potentially relevant tie between physicians and commercial interests, every medical...
Read More
Top 10 for ’09: No. 5
No. 5: Allergan Challenges FDA’s Speech Restrictions In what may turn out to be a pivotal case on the rights of commercial speech, Allergan, the maker of Botox...
Read More
BMJ Editor Bitch Slaps* Roche
What do we want? Raw data! When do we want it? Now! In the midst of the 2009 pandemic influenza epidemic, BMJ editor Fiona Godlee takes Roche to task for not supplying...
Read More
Spending Rally on DTC Drug Ads?
For what it’s worth (perhaps a teeny-tiny indicator of an economic rebound?), pharma’s spending on direct-to-consumer (DTC) advertising increased...
Read More
CBO: Latest Snapshot of Pharma’s Promotional Spending
While news outlets focus on pharma’s investment in direct-to-consumer (DTC) advertising, the Congressional Budget Office reminds us that the drug industry spends...
Read More